TrialCell transplantation

Human Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Multiple Sclerosis Patients: Phase I/II Dose-Finding Clinical Study.

Fatima Jamali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.